| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | £3.59B | +3.5% |
| Gross Profit | £954.0M | +16.1% |
| EBITDA | — | — |
| Net Income | £370.0M | — |
| Diluted EPS | £0.29 | — |
| Free Cash Flow | £128.0M | — |
| DPS (FY2025) | £0.05 |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | 2 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | £0.05 | +20.0% | reported |
| FY20242024-12-31 | £0.04 | +14.3% | reported |
| FY20232023-12-31 | £0.04 | — | reported |
| FY20222022-12-31 | — | — | reported |
| FY2021 |
| Ratio | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 5y | vs own |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| Gross Margin | 13.53% | 14.25% | 19.52% | 23.70% | 26.58% | 90% | |
| Operating Margin | −7.41% | −9.14% | 1.70% | −0.12% | 16.72% | 90% | |
| NOPAT Margin | −5.86% | −7.22% | 1.34% | −0.09% | 13.22% | 90% | |
| Net Margin | 12.53% | −10.43% | −30.42% | −1.41% | 10.31% | 70% | |
| FCF Margin | 0.68% | 4.57% | −1.97% | −6.60% | 3.57% | 70% | |
| FCFF Margin | — | — | — | — | 6.47% | — | 50% |
| FCFE Margin | −22.71% | 5.72% | −24.15% | 15.22% | 9.95% | 70% | |
| OCF Margin | 3.95% | 6.91% | 0.87% | −3.49% | 5.96% | 70% | |
| Gross Profitability | 6.42% | 2.97% | 9.21% | 11.05% | 12.56% | 90% | |
| Capex Intensity | 3.28% | 2.34% | 2.84% | 3.11% | 2.40% | 30% | |
| ▸Returns on Capital · 6 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||
| ▸Earnings quality · 5 ratios | |||||||
| ▸Liquidity & coverage · 7 ratios | |||||||
| ▸Leverage · 8 ratios | |||||||
| ▸Working capital · 8 ratios | |||||||
| ▸Capital allocation · 5 ratios | |||||||
| ▸Other · 1 ratios | |||||||
The five drivers multiply to 13.2% vs reported ROE 13.0%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | £6.65B | £2.95B | £3.35B | £3.47B | £3.59B |
| YoY % | -55.6% | +13.4% | +3.5% | +3.5% | |
| Cost of Revenue | £5.75B | £2.53B | £2.70B | £2.65B | £2.63B |
| YoY % | -55.9% | +6.4% | -1.9% | -0.4% | |
| Gross Profit | £900.0M | £421.0M | £654.0M | £822.0M | £954.0M |
| YoY % | -53.2% | +55.3% | +25.7% | +16.1% | |
| Total Operating Expenses | £1.43B | £691.0M | £597.0M | £826.0M | £354.0M |
| YoY % | -51.7% | -13.6% | +38.4% | -57.1% | |
| Operating Income | -£493.0M | -£270.0M | £57.0M | -£4.0M | £600.0M |
| Interest Expense | £169.0M | £83.0M | £79.0M | £105.0M | £132.0M |
| YoY % | -50.9% | -4.8% | +32.9% | +25.7% | |
| Interest & Investment Income | £2.0M | £25.0M | £14.0M | £3.0M | £0 |
| YoY % | +1150.0% | -44.0% | -78.6% | -100.0% | |
| Equity Method Income | £38.0M | £49.0M | — | — | — |
| YoY % | +28.9% | ||||
| Pretax Income | -£660.0M | -£328.0M | -£8.0M | -£106.0M | £468.0M |
| Income Tax | -£180.0M | -£99.0M | -£9.0M | -£57.0M | £98.0M |
| Income from Continuing Operations | -£480.0M | -£229.0M | £1.0M | -£49.0M | — |
| Income from Discontinued Operations | £1.32B | -£74.0M | -£1.02B | £0 | — |
| Net Income (incl. NCI) | £837.0M | -£303.0M | -£1.02B | -£49.0M | £370.0M |
| Minority Interest (P&L) | £4.0M | £5.0M | £0 | — | — |
| YoY % | +25.0% | -100.0% | |||
| Net Income | £833.0M | -£308.0M | -£1.02B | — | — |
| EPS (Basic) | — | — | -£0.76 | -£0.04 | £0.29 |
| EPS (Diluted) | — | — | -£0.76 | -£0.04 | £0.29 |
| Dividends Declared per Share | — | — | £0 | £0 | £0 |
| YoY % | +14.3% | +20.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| — |
| — |
| reported |
